Skip to main content

A potential correlation between adipokines, skeletal muscle function and bone mineral density in middle-aged and elderly individuals



Evidence exists of a strong association between inflammation and a decrease in skeletal muscle function and bone mineral density (BMD); however, the specific mechanisms of these associations remain unclear. Adipokines, as key regulators of the inflammatory response, may be implicated in these processes. The objective of this study was to explore the potential correlation between adipokines, skeletal muscle function and BMD in middle-aged and elderly individuals.


A comparative cross-sectional study was carried out at the Huadong Hospital Affiliated with Fudan University (Shanghai, China). A total of 460 middle-aged and elderly individuals were recruited, and 125 were enrolled in the analysis. Their biochemical indices, body composition, skeletal muscle function and BMD were measured. Bioinformatic analysis was also employed to identify potential adipokine targets linked to skeletal muscle function and BMD. To validate these targets, plasma and peripheral blood mononuclear cells (PBMCs) were harvested from these individuals and subjected to western blotting (WB) and enzyme-linked immunosorbent assay (ELISA).


Individuals in this cross-sectional study were categorized into 2 groups according to their median skeletal muscle mass (SMM) (28.8 kg for males and 20.6 kg for females). Individuals with lower SMM exhibited poorer grip strength (P = 0.017), longer 5-Times-Sit-to-Stand Test (FTSST) duration (P = 0.029), lower total hip BMD (P = 0.043), lower femoral neck BMD (P = 0.011) and higher levels of inflammatory markers in comparison with individuals with higher SMM. Bioinformatics analysis identified LEP, ADIPOQ, RBP4, and DPP4 as potential adipokine targets associated with skeletal muscle function and BMD. In vitro experiments demonstrated that individuals with decreased skeletal muscle function and BMD expressed higher levels of these adipokines.


Skeletal muscle function is positively correlated with BMD and negatively correlated with levels of inflammatory markers among middle-aged and elderly individuals. Those with lower skeletal muscle function and BMD tend to have a higher expression of LEP, ADIPOQ, RBP4 and DPP4.


Decreased skeletal muscle function is a common issue among elderly individuals [1]. Recent studies suggest that lipids and adipokines in skeletal muscle may be responsible for this condition. Intramyocellular lipids (IMCLs) can accumulate in skeletal muscle during aging, which results in inflammation, impaired mitochondrial oxidative phosphorylation and decreased skeletal muscle function [2]. Adipocytes present in skeletal muscle can also interfere with the normal expression of adipokines, resulting in inflammatory reactions [3], catabolism and damage to skeletal muscle regeneration [4]. Inflammation is a risk factor for skeletal muscle health, and PBMCs are associated with the induction and propagation of inflammation. PBMCs are capable of releasing numerous inflammatory mediators and proinflammatory cytokines [5] by producing adipokines or being activated by adipokines [6, 7] to drive ongoing chronic inflammation, ultimately leading to a decline in skeletal muscle function.

Osteoporosis is an age-related disease characterized by decreased bone strength and mass, which poses a serious threat to both the patient’s lifespan and quality of life. According to an epidemiological study, over 50% of American adults aged 50 and above suffer from decreased BMD, and among them, 1/3 of women and 1/5 of men may experience an osteoporotic fracture at some point during their remaining lifetime [8, 9]. Numerous studies have indicated a significant correlation between BMD and skeletal muscle function [10,11,12]. Skeletal muscle regulates bone metabolism through the endocrine system and mechanical loading, while bones can affect the development of skeletal muscle from local or humoral factors [13]. When the interaction between these tissues is disrupted, both BMD and skeletal muscle function tend to decline simultaneously. Adipokines, which function as modulators of inflammation, have recently been suggested to have a potential adverse effect on this interaction [14, 15].

Decreased skeletal muscle function and osteoporosis are both proinflammatory conditions, and adipokines may promote the activation of inflammation in these processes. Understanding the impact of adipokines on inflammation, skeletal muscle function and BMD may contribute to the development of new treatment strategies against sarcopenia or osteoporosis. In this study, we hypothesized that higher levels of adipokines and inflammatory markers are related to decreased skeletal muscle function and decreased BMD in middle-aged and elderly individuals. Specifically, the relationship between inflammatory markers, skeletal muscle function and BMD was comprehensively assessed by a cross-sectional study. Three public RNA-seq datasets were analyzed using bioinformatics techniques to identify potential adipokine targets in the connection between skeletal muscle function and BMD. Finally, based on the cross-sectional study, the protein levels of LEP and ADIPOQ in PBMCs were evaluated, while the levels of LEP, ADIPOQ, RBP4, DPP4, IL-8 and TNF-α in plasma were evaluated through ELISA so that differences in the expression of these targets among middle-aged and elderly individuals with varying skeletal muscle function and BMD were validated.

Materials and methods

Our study workflow is shown in Fig. 1.

Fig. 1
figure 1

Schematic diagram of the workflow conducted in this study

Study design of the comparative cross-sectional study

In this study, we conducted a comparative cross-sectional study on middle-aged and elderly individuals (age: 50–90 years) who visited the inpatient department and outpatient department of Huadong Hospital from July 1, 2021, to March 30, 2022. Altogether, 125 eligible individuals were assessed, and the inclusion and exclusion criteria are shown in Fig. 2. Individuals were then grouped according to gender and median SMM. In their respective sexes, those with higher SMM were assigned to group 1, while those with lower SMM were assigned to group 2. Our research protocol received approval from the Ethics Committee of Huadong Hospital (Approval no. 2021K114), and we conducted this work following the Declaration of Helsinki guidelines.

Fig. 2
figure 2

Participant flow in the comparative cross-sectional study

Body composition was assessed using Bioelectrical Impedance Analysis (InBody 770), which included measurements for height, weight, body fat mass, SMM, muscle mass in four extremities, trunk muscle mass, and basal metabolic rate. We calculated appendicular skeletal muscle mass (ASM) by adding up the muscle mass of all four limbs and determined the skeletal muscle index (SMI) by dividing ASM by height squared. We measured skeletal muscle function using grip strength and FTSST. To measure grip strength, we used the CAMRY electronic hand dynamometer and measured the dominant hand’s grip strength in a seated position with the elbow straightened. The FTTST was conducted to evaluate the individuals’ lower limb function. During the test, individuals were instructed to sit at the edge of a chair with their arms folded and repeatedly tap their buttocks against the chair as quickly as possible.

BMD and T scores of the lumbar spine, total hip, and femoral neck were assessed with dual-energy X-ray absorptiometry (DXA). BMD was measured in g/cm2. Osteopenia was considered at a T score below − 1, and osteoporosis was considered at a T score <–2.5, according to guidelines released by the World Health Organization.

Blood was sampled from individuals in the morning after a 12-hour fast and analyzed in the laboratory of Huadong Hospital. We measured the estimated glomerular filtration rate (eGFR) to evaluate kidney function using the Chronic Kidney Disease Epidemiology Collaboration equation. Serum creatinine (Scr), blood urea nitrogen (BUN), serum uric acid (SUA), aspartate transaminase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), triglycerides (TG), total cholesterol (TC), high- and low-density lipoprotein (HDL/LDL), glycated hemoglobin (HbA1c), IL-6 and C-reactive protein (CRP) levels were measured. Information about individuals’ history of alcohol consumption and smoking was obtained in face-to-face interviews.

Data acquisition and preprocessing

Three RNA-seq datasets (GSE111006, GSE111010, and GSE111016) containing skeletal muscle samples of older males were obtained based on the Gene Expression Omnibus (GEO) database. In line with differences in clinical phenotypes, skeletal muscle samples with low skeletal muscle function were assigned to the skeletal muscle function decrease group. In contrast, samples with normal skeletal muscle function were assigned to the control group. Therefore, the skeletal muscle function decrease group consisted of 33 skeletal muscle samples, whereas the control group included 42 skeletal muscle samples.

Identification of differentially expressed genes (DEGs) and Kyoto Encyclopedia of genes and genomes (KEGG) analysis

Differential expression analysis was carried out with the “limma” R package for identifying DEGs. The cutoff criteria were adj.P.Val < 0.05 and |log2FC|>1. The “heatmap” R package was adopted for result visualization. KEGG analysis was conducted with the “clusterProfiler” R package to identify DEG-enriched functions and pathways. The cutoff criteria for this analysis were P.Val < 0.05 and |log2FC|>1.

Immune-related genes (IRGs) and immune cell infiltration analysis

We downloaded 1793 nonredundant IRGs based on the ImmPort database and determined IRGs related to skeletal muscle function using the “ggplot2” R package. In addition, immune cell proportions in muscle biopsy samples were quantified using the CIBERSORT algorithm. The “heatmap” R package was employed to draw a heatmap to visualize the correlation between immune cells and IRGs. The “ggplot2” R package was utilized to compare immune cell infiltration levels between the 2 groups.

Screening of adipokine targets between skeletal muscle function and BMD

Osteoporosis-related genes were acquired based on the DisGeNET database. Meanwhile, the Venn diagram displayed the shared targets between skeletal muscle function and osteoporosis. We subjected these shared targets to Gene Ontology (GO) annotation with the “clusterProfiler” R package to identify functions and pathways associated with the shared targets in greater detail. We also built a protein–protein interaction (PPI) network for common targets using the STRING database (, with a confidence score of > 0.4 as a cutoff criterion. Cytoscape 3.8.0 software was used to further screen adipokine targets and visualize them.

Blood sampling

Peripheral blood samples were collected from eligible individuals. To obtain plasma, the collected samples were then added to EDTA-coated tubes for a 5-min centrifugation at 500×g. PBMCs were extracted in peripheral blood through Ficoll-Hypaque density gradient centrifugation with Lymphoprep (Stemcell Technologies, Shanghai, China). All stock solutions were preserved at − 80 °C. Individuals in this work were voluntary and provided informed consent.

Western blotting assay

We utilized RIPA lysis buffer (BioLegend, England) to extract total PBMC proteins, separated the proteins through SDS‒PAGE, and later transferred the proteins to PVDF membranes. Membranes were later subjected to 1-h blocking at ambient temperature and overnight incubation with primary antibodies (LEP rabbit pAb and ADIPOQ rabbit pAb) (1:1000, ABclonal Technology, Wuhan, China) at 4 °C. Thereafter, the membranes were rinsed with TBST (1×TBS and 0.5% Tween-20, pH 7.4) three times (10 min each), followed by secondary antibody incubation (HRP-labeled goat anti-rabbit IgG, ABclonal Technology) at a 1:2000 dilution at ambient temperature for 60 min. Chemiluminescence was conducted, and the results were photographed. Each experiment was repeated three times.


The plasma levels of LEP, ADIPOQ, RBP4, DPP4, IL-8 and TNF-α were measured by ELISA following specific protocols (Elabscience Biotechnology, Wuhan, China). Each standard and sample were loaded together with the corresponding antibodies in all wells in a micro-ELISA plate, and then excessive avidin-HRP-conjugated secondary biotinylated antibodies were added. The nonbinding components were removed by rinsing. Substrates and stop solutions were then added, and absorbance (OD) values were detected using a spectrophotometer at 450 nm. Each assay was conducted three times.

Statistical analyses

Continuous variables were represented by mean ± SD and analyzed by t test or Mann-Whiney U test, while categorical variables were represented by numbers and percentages and analyzed with a chi-square test. We conducted binary logistic regression analysis and Spearman’s correlation analysis to evaluate the relationship of skeletal muscle parameters with BMD. Stata 16.0 was the statistical software used for this analysis. P < 0.05 (two-sided) indicated a significant difference.


The association between inflammatory markers, skeletal muscle function and BMD among middle-aged and elderly individuals

A total of 125 individuals were included in the present work. The median SMM for males and females was 28.8 and 20.6 kg, respectively. Sixty-nine individuals with higher SMM were assigned to Group 1, and 56 with lower SMM were assigned to Group 2. Table 1 displays the basic characteristics. No significant differences between the 2 groups were noted in alcohol consumption, smoking history, or biochemical indices. Although triglyceride levels were significantly different between the 2 groups (P = 0.021), these levels were not found to be related to any parameter of skeletal muscle or BMD values (see Supplementary File 1 for details).

Table 1 The baseline characteristics of Group 1 and Group 2

Table 2; Fig. 3 display the body composition, skeletal muscle function and BMD characteristics. Differences in BMI and body fat mass were not significant between the 2 groups. However, Group 2 exhibited lower levels of body composition parameters, including SMM, muscle mass of four extremities, trunk muscle mass, ASM, SMI, and basal metabolic rate, compared to Group 1 (P < 0.05). Individuals in the 2 groups exhibited differences in grip strength and FTTST. Group 1 patients performed better in grip strength and FTTST than Group 2 patients. Specifically, grip strength (P = 0.017) was decreased, and FTTST was increased (P = 0.029) in Group 2 in comparison with Group 1. BMD and the numbers of individuals with osteopenia or osteoporosis were significantly different between the 2 groups. Except for lumbar spine BMD (P = 0.833), femoral neck BMD (P = 0.011) and total hip BMD (P = 0.043) of Group 2 individuals were decreased compared to Group (1) Out of the 40 individuals with osteoporosis, 17 belonged to Group 1, and 23 belonged to Group (2) Moreover, out of the 106 individuals diagnosed with osteopenia or osteoporosis, 53 were in Group 1, and 53 were in Group 2. The number of individuals diagnosed with osteopenia and osteoporosis in Group 2 dramatically increased compared with Group 1 (P = 0.006).

Table 2 Basic information, body composition, skeletal muscle function and BMD of Group 1 and Group 2
Fig. 3
figure 3

(A-B) Differences in age, body composition and skeletal muscle function between Group 1 and Group 2. (C) Bar charts of body composition and skeletal muscle function, presented as the mean ± standard deviation. P values were 2-sided, and values < 0.05 were considered to be significantly important

As shown in Table 3, IL-6 (P = 0.049) and CRP (P < 0.001), 2 inflammatory markers, were found to be different between the 2 groups. The expression levels of IL-6 and CRP in Group 1 were significantly decreased compared with those in Group 2. Then, we examined the correlation between IL-6 and CRP and various body parameters, including body fat mass, grip strength, SMM, lumbar spine BMD, total hip BMD and femoral neck BMD. IL-6 was significantly associated with all of the aforementioned parameters. Specifically, IL-6 was positively correlated with body fat mass (P = 0.013) and negatively correlated with grip strength (P = 0.008), SMM (P = 0.029) and BMD values. On the other hand, CRP was only negatively correlated with BMD values and had no correlation with body fat mass, grip strength or SMM.

Table 3 The levels of IL-6 and CRP and the correlation between IL-6 and CRP and parameters of fat, skeletal muscle and BMD.

We also analyzed the correlation between skeletal muscle content (SMM and SMI), skeletal muscle function (grip strength and FTTST), and BMD in all 125 individuals. Our findings, represented in Fig. 4, indicate a significant correlation between skeletal muscle content, skeletal muscle function, and BMD (P < 0.01). Specifically, we observed positive correlations between SMM, SMI, grip strength, and BMD, while negative correlations were noted between FTTST and BMD.

Fig. 4
figure 4

(A) Scatter plots show the correlation between skeletal muscle parameters and BMD. The gray part indicates the 95% confidence interval. The ROC curves represent the performance of the prediction of osteopenia or osteoporosis through SMI. (B) SMM. (C) Grip strength. (D) FTTST. P values were 2-sided, and values < 0.05 were considered to be significantly important. Abbreviations: SMI, skeletal muscle mass index; BMD, bone mineral density; ROC, receiver operating characteristic; FTTST, 5-times sit-to-stand test

Bioinformatics analysis revealed immune homeostasis and adipokines associated with skeletal muscle function

We retrospectively analyzed 33 samples with decreased skeletal muscle function and 42 control samples from GSE111006, GSE111010, and GSE111016. A total of 283 DEGs were detected, among which 230 showed upregulation, whereas 53 displayed downregulation. The heatmap in Fig. 5A demonstrates that these 2 groups were significantly different. More details of these genes can be found in Supplementary File 2. To obtain a preliminary understanding of these DEGs, we conducted KEGG enrichment for both upregulated and downregulated DEGs separately. The top 27 downregulated DEG-enriched notable KEGG pathways and the top 12 upregulated DEG-enriched KEGG pathways were demonstrated. These pathways were related to various biological processes, such as the immune response, bone metabolism, inflammation, and lipids (Fig. 5B-C).

Fig. 5
figure 5

(A) Heatmap of DEGs. (B) KEGG analysis based on downregulated DEGs. (C) KEGG analysis based on upregulated DEGs. Abbreviation: DEGs, differentially expressed genes; KEGG, Kyoto Encyclopedia of Genes and Genomes

Twenty-six IRGs were identified by screening DEGs using the ImmPort database. These IRGs included CRHR2, ACKR2, ADIPOQ, FGF18, ANGPTL5, ELN, PLA2G2A, SEMA3D, RBP4, PTGER3, PTHLH, FGF7P3, CCL21, ANGPTL7, CXCL2, AZGP1, S100B, RORB, LEP, MARCO, CCL13, LHCGR, OGN, FOS, BMP7, and CXCL8. Details of these genes are provided in Supplementary File 3. Notably, ADIPOQ, LEP, and RBP4 were involved in lipid metabolism. Additionally, these 3 genes were all overexpressed in samples with decreased skeletal muscle function compared to control samples.

The CIBETSORT algorithm was utilized to evaluate immune cell infiltration associated with skeletal muscle function. The correlation between IRGs and immune cell infiltration was analyzed (Fig. 6). We observed a significantly lower proportion of naïve CD4 T cells in the skeletal muscle function decrease samples than in the control samples (P = 0.042). Furthermore, we found a significantly higher proportion of resting NK cells in the skeletal muscle function decrease samples (P = 0.003). Additionally, the proportion of monocytes was significantly reduced in the skeletal muscle function decrease samples (P = 0.005). The study found that the proportions of monocytes (P = 0.005) and resting mast cells (P < 0.001) significantly declined in samples with decreased skeletal muscle function, while the proportion of eosinophils increased significantly (P = 0.007). The study also found a universal correlation between NK cells, monocytes, macrophages, resting mast cells, eosinophils, neutrophils, and IRGs.

Fig. 6
figure 6

(A) Correlation heatmap of immune cells and IRGs. Red indicates a positive correlation, while blue indicates a negative correlation. (B) Grouped comparison histogram of immune infiltration. *P < 0.05; **P < 0.01. P values were 2-sided, and values < 0.05 were considered to be significantly important. Abbreviations: IRGs, immune-related genes

LEP, ADIPOQ, RBP4, DPP4 and CXCL8 are potential meditators between skeletal muscle function and BMD

Twenty-one common targets were identified between skeletal muscle function and BMD (Fig. 7A). These targets included ADIPOQ, AEBP1, ANGPTL7, BMP7, COMP, CXCL8, DPP4, ELN, FOS, FOSB, LEP, LINC00311, OGN, PDE8B, POF1B, POSTN, PTHLH, RBP4, SLCO2A1, TWIST1, and U2AF1. Their biological process (BP), molecular function (MF), and cellular component (CC) are shown in Fig. 7B. The STRING database was utilized to construct the PPI network for these genes, with a target being excluded due to missing data. This PPI network consisted of 20 nodes and 22 edges, and the mean node degree and mean local clustering coefficient were 2.2 and 0.47, respectively. As illustrated in Fig. 7C, the P value of PPI enrichment was 1.02e-09. We further analyzed the targets in the PPI network using Cytoscape 3.8.0 software (Fig. 7D). We identified 4 adipokine targets, LEP, ADIPOQ, RBP4 and DPP4, that were closely related in the network. In addition, CXCL8 was observed to be associated with these adipokines.

Fig. 7
figure 7

(A) Intersection of DEGs and osteoporosis-related genes in the DisGeNET database. (B) GO analysis of common targets between deceased skeletal muscle function and osteoporosis. (C) PPI network of common targets. Confidence score: > 0.4. (D) Major common targets in PPI work. Abbreviations: DEGs, differentially expressed genes; GO, Gene Ontology; PPI, protein–protein interaction; BP, biological process; CC, cellular component; MF, molecular function

The expression levels of LEP, ADIPOQ, RBP4, DPP4, CXCL8 and TNF-α were relatively increased in individuals in Group 2 compared to those in Group 1

Ten individuals were selected from each group, and their whole blood was extracted to isolate PBMCs. LEP and ADIPOQ levels within PBMCs were measured using WB. As shown in Fig. 8A-B, LEP (P = 0.0469) and ADIPOQ (P = 0.0175) expression was relatively upregulated in the PBMCs of Group 2 individuals in comparison with Group 1 individuals. In addition, blood samples were collected from 12 individuals in each group and separated into plasma. We assessed the expression levels of LEP, ADIPOQ, RBP4, DPP4, CXCL8 (also known as IL-8) and TNF-α in the plasma of both groups using ELISA. According to Fig. 8C, while the difference in plasma LEP level was not significant (P = 0.2633) between groups, Group 2 individuals displayed apparently increased plasma ADIPOQ (P = 0.0255), RBP4 (P = 0.0158), DPP4 (P = 0.0244), IL-8 (P = 0.018) and TNF-α (P = 0.0055) levels than Group 1 individuals. It was found that there was relative consistency in the expression levels of adipokines in both PBMCs and plasma among middle-aged and elderly individuals in this cross-sectional study, thereby indicating that adipokine expression may be crucial for skeletal muscle function and BMD.

Fig. 8
figure 8

(A) The expression of LEP and ADIPOQ in PBMCs of included participants in Group 1 (n = 10) and Group 2 (n = 10). β-actin was used as the internal reference gene. (B) Relative expression of LEP and ADIPOQ in PBMCs measured by WB (n = 10 each). (C) The plasma levels of LEP, ADIPOQ, RBP4, DPP4, IL-8 and TNF-α were measured by ELISA in Group 1 (n = 12) and Group 2 (n = 12). P values were 2-sided, and values < 0.05 were considered to be significantly important. Abbreviations: LEP, leptin; ADIPOQ, adiponectin; SMM, skeletal muscle mass; PBMCs, peripheral blood mononuclear cells; WB, western blotting; RBP4, retinol binding protein 4; DPP4, dipeptidyl peptidase 4; IL-8, interleukin-8; TNF-α, tumor necrosis factor-α


Both sarcopenia and osteoporosis are linked with numerous negative outcomes, including fractures, falls, hospitalization or disability [16]. Given the global aging population, it is important to investigate the mechanism between skeletal muscle function and BMD to establish effective clinical decision-making strategies. Previous research has demonstrated a relationship between inflammation, skeletal muscle and BMD [2, 17,18,19]. The objective of this study was to explore the potential correlation between adipokines, skeletal muscle function and BMD. The results revealed a significant correlation between these factors. Middle-aged and elderly individuals with lower skeletal muscle function and BMD had higher expression levels of LEP, ADIPOQ, RBP4, DPP4 and inflammatory markers, suggesting that adipokines may play a role in the activation of inflammation and lead to the development of sarcopenia and osteoporosis.

Our cross-sectional study found a significant association between skeletal muscle content, skeletal muscle function and BMD. Specifically, higher levels of SMM and worse skeletal muscle function were related to decreased BMD and a higher osteoporosis risk. These findings support the notion that aging skeletal muscle is strongly linked to osteoporosis, which is mentioned in some articles. Simon et al. investigated the relationship between skeletal muscle function and bone microarchitecture in females. They discovered a significant correlation between skeletal muscle strength, cortical bone thickness, and bone cortical area, highlighting the importance of assessing muscle function in evaluating fracture risk [20]. Kuriyama et al. examined the correlation between skeletal muscle and osteoporosis among middle-aged and old people in Japan and found that male subjects with lower SMM were more likely to develop osteoporosis [21].

The relationships between inflammatory markers (IL-6, IL-8, CRP and TNF-α) and various parameters related to fat, skeletal muscle and BMD were also investigated. Our findings revealed that higher levels of inflammatory markers are generally associated with increased body fat mass, decreased grip strength, decreased SMM and higher BMD in these individuals, which aligned with the observed expression condition of adipokines. IL-6, working as a pro-inflammatory factor, can selectively stimulate protein degradation and promote fat synthesis in human skeletal muscle [22]. TNF-α is secreted by both adipose tissue and skeletal muscle, and its presence can hinder muscle protein synthesis by promoting insulin resistance [23]. In addition, IL-6 and TNF-α can enhance the bone resorption capacity of PBMCs, stimulate the formation of osteoclasts and contribute to the development of osteoporosis [24]. IL-8 and CRP are nonspecific inflammatory markers. Several clinical studies have established a significant correlation between elevated levels of IL-8 and CRP and conditions such as obesity, sarcopenia, and osteoporosis [25]. However, CRP in this study was not correlated with body fat mass, grip strength or SMM, which may be attributable to its lower sensitivity in predicting fat or skeletal muscle compared with IL-6 [26, 27].

By utilizing bioinformatics methods, we identified that LEP, ADIPQO, RBP4 and DPP4 are associated with decreased skeletal muscle function. This discovery reinforces the conclusion that increased adipokine levels may have adverse effects on the physiological function of skeletal muscles [28, 29]. Relationships between adipokines, skeletal muscle and bone metabolism are intricate. Leptin and adiponectin work together to maintain muscular function. Leptin is produced by subcutaneous fat and skeletal muscle [30] and activates the AMPK/ERK pathway to regulate protein metabolism in skeletal muscle [31]. Leptin has a bidirectional regulatory effect on bone, affecting both anabolism and catabolism, with its effects influenced by the presence of a central relay. Moreover, leptin has been shown to have proinflammatory effects and to promote the generation of proinflammatory factors such as IL-6 and TNF-α in macrophages and monocytes [32]. On the other hand, adiponectin is mainly secreted [33] by brown adipose tissue, which exerts an essential function in promoting mitochondrial synthesis and activating the AMP-activated protein kinase (AMPK) pathway [34]. Adiponectin has been found to increase extracellular calcium influx via adiponectin receptor 1 (AdipoR1), thus upregulating peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) and mitochondria in muscle cells [35]. However, clinical trials have shown that adiponectin has a negative relationship with BMD in obese humans [36,37,38]. In a human coculture system containing PBMCs, adiponectin can promote the differentiation of osteoclasts in an osteoblast-dependent manner [39]. Additionally, a study showed that high-molecular-weight adiponectin can enhance IL-8 translation by human macrophages [40], which is consistent with our analysis of the PPI network.

RBP4 is a cytokine that is secreted by adipose tissue and has proinflammatory properties. Studies have shown that RBP4 can lead to insulin resistance and affect protein anabolism in skeletal muscle indirectly, particularly under the stimulation of peroxisome proliferator-activated receptor-gamma (PPARγ) agonists [41]. Additionally, RBP4 has been found to activate adipose tissue macrophages and prime the NLRP3 inflammasome to produce IL-1β, IL-6 and TNF-α through Toll-like receptors 2/4 [42, 43]. A clinical study has shown that circulating RBP4 levels are closely related to SMM and muscle function among elderly individuals, making it a useful biomarker for screening sarcopenia [44]. DPP4 was identified as another adipokine that could be linked to skeletal muscle function and BMD in this study. DPP4 can produce IL-6 and TNF-α [45, 46] and exacerbate inflammation mediated by adipose tissue macrophages by interacting with adenosine deaminase (ADA) and other extracellular matrix proteins [47]. DPP4 can also impair the insulin signaling pathway, thereby contributing to insulin resistance [47]. Recent research has reported that elevated levels of DPP4 in elderly diabetes patients possibly induce the reduced mass and function of skeletal muscle [48, 49]. In addition, DPP4 has obvious negative effects on bone tissue. Zhang et al. discovered that higher levels of DPP4 are related to low BMD in postmenopausal women as well as a higher osteoporosis risk [50].

Study strengths and limitations

This study has several advantages. Samples assigned to 2 groups in the cross-sectional study were middle-aged and elderly individuals at similar ages, thus avoiding the interference of natural aging on skeletal muscles to the maximum extent. This study examined the correlation between BMD and skeletal muscle function from the perspective of adipokines and suggests that adipokines could be the key factors responsible for the degeneration of bone and skeletal muscle. Notably, our findings reveal for the first time that the protein levels of leptin and adiponectin within PBMCs can impact muscle mass and function. These clinically relevant findings could pave the way for developing new treatments to elevate skeletal muscle function in the future. This study, however, has notable shortcomings. Our clinical study had a small sample size, which has limited the ability to adjust for potential confounding factors. For instance, although there were differences in TG levels between the two groups, our study did not find any correlation between TG and skeletal muscle parameters or BMD. In addition, no follow-up was performed in this study, and future studies should incorporate a follow-up period to clarify the long-term impact of adipokines on skeletal muscle function. Moreover, we did not perform in vivo experiments to validate our conclusion.


Our clinical study and in vitro experiments have shown that individuals with decreased skeletal muscle function exhibit increased expression of LEP, ADIPOQ, RBP4, DPP4 and inflammatory markers. The increased levels of adipokines in skeletal muscle are possibly associated with a decrease in BMD and the occurrence of osteoporosis among middle-aged and elderly individuals. More research on the implications of this relationship and the development of effective clinical treatments are needed.

Data Availability

Data used in this work can be obtained from the corresponding author upon request.



Skeletal muscle mass


Skeletal muscle mass index


Intramyocellular lipids


Peripheral blood mononuclear cells


Bone mineral density


Western blotting


Alanine aminotransferase


World Health Organization


Estimated glomerular filtration rate


Serum creatinine


Blood urea nitrogen


Serum uric acid


Aspartate transaminase


Alkaline phosphatase




Total cholesterol


High-density lipoprotein


Low-density lipoprotein


Glycated hemoglobin


C-reactive protein


Gene Expression Omnibus


Differentially expressed genes


Kyoto Encyclopedia of Genes and Genomes


Immune-related genes


Principal component analysis


Receiver operating characteristic


Area under the curve


Precision-recall curve


Gene ontology


Protein‒protein interaction


Appendicular skeletal muscle mass


5-Times Sit-to-Stand Test


Avidin-Horseradish Peroxidase


Biological process


Molecular function


Cellular component


AMP-activated protein kinase


Peroxisome proliferator-activated receptor gamma coactivator-1α


Adiponectin receptor 1


Peroxisome proliferator-activated receptor-gamma


Adenosine deaminase


  1. Cruz-Jentoft AJ, et al. Sarcopenia: european consensus on definition and diagnosis: report of the european Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–23.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Al Saedi A, et al. Lipid metabolism in sarcopenia. Bone. 2022;164:116539.

    Article  CAS  PubMed  Google Scholar 

  3. Gu X, et al. Adipose tissue adipokines and lipokines: functions and regulatory mechanism in skeletal muscle development and homeostasis. Metab Clin Exp. 2023;139:155379.

    Article  CAS  PubMed  Google Scholar 

  4. Calvani R, et al. Systemic inflammation, body composition, and physical performance in old community-dwellers. J Cachexia Sarcopenia Muscle. 2017;8(1):69–77.

    Article  PubMed  Google Scholar 

  5. Fan Z, et al. Altered levels of circulating mitochondrial DNA in elderly people with sarcopenia: Association with mitochondrial impairment. Exp Gerontol. 2022;163:111802.

    Article  CAS  PubMed  Google Scholar 

  6. Bai Z, et al. Leptin promotes glycolytic metabolism to induce dendritic cells activation via STAT3-HK2 pathway. Immunol Lett. 2021;239:88–95.

    Article  CAS  PubMed  Google Scholar 

  7. Mahmoud FF, et al. Correlation between heat shock proteins, adiponectin, and T lymphocyte cytokine expression in type 2 diabetics. Cell Stress & Chaperones. 2018;23(5):955–65.

    Article  CAS  Google Scholar 

  8. Wright NC, et al. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 2014;29(11):2520–6.

    Article  PubMed  Google Scholar 

  9. Adams J, et al. 2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older. Ann Rheum Dis. 2021;80(1):57–64.

    Article  PubMed  Google Scholar 

  10. Qi H, et al. Bone mineral density and trabecular bone score in chinese subjects with sarcopenia. Aging Clin Exp Res. 2019;31(11):1549–56.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Locquet M et al. Bone health assessment in older people with or without muscle health impairment Osteoporosis International: a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the USA, 2018. 29(5): p. 1057–67.

  12. Sipilä S, et al. Muscle and bone mass in middle-aged women: role of menopausal status and physical activity. J Cachexia Sarcopenia Muscle. 2020;11(3):698–709.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kawao N, Kaji H. Interactions between muscle tissues and bone metabolism. J Cell Biochem. 2015;116(5):687–95.

    Article  CAS  PubMed  Google Scholar 

  14. Mangano KM, et al. Polyunsaturated fatty acids and their relation with bone and muscle health in adults. Curr Osteoporos Rep. 2013;11(3):203–12.

    Article  PubMed  Google Scholar 

  15. Lee S, et al. Effect of adipokine and ghrelin levels on BMD and fracture risk: an updated systematic review and meta-analysis. Front Endocrinol. 2023;14:1044039.

    Article  Google Scholar 

  16. Almohaisen N et al. Prevalence of Undernutrition, Frailty and Sarcopenia in Community-Dwelling People aged 50 years and above: systematic review and Meta-analysis. Nutrients, 2022. 14(8).

  17. Livshits G, Kalinkovich A. Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis. Ageing Res Rev. 2019;56:100980.

    Article  CAS  PubMed  Google Scholar 

  18. Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev. 2017;35:200–21.

    Article  CAS  PubMed  Google Scholar 

  19. Wilson D, et al. Frailty and sarcopenia: the potential role of an aged immune system. Ageing Res Rev. 2017;36:1–10.

    Article  PubMed  Google Scholar 

  20. Simon A, et al. Compartment-specific effects of muscle strength on bone microarchitecture in women at high risk of osteoporosis. J Cachexia Sarcopenia Muscle. 2022;13(5):2310–21.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kuriyama K, et al. Relationship between sarcopenia classification and thigh muscle mass, fat area, muscle CT value and osteoporosis in middle-aged and older japanese adults. Bone. 2022;163:116487.

    Article  PubMed  Google Scholar 

  22. Hong S-H, Choi KM. Sarcopenic obesity, insulin resistance, and their implications in Cardiovascular and metabolic consequences. Int J Mol Sci, 2020. 21(2).

  23. Yao Z, Getting SJ, Locke IC. Regulation of TNF-Induced Osteoclast differentiation. Cells, 2021. 11(1).

  24. Yokota K, et al. Characterization and function of Tumor Necrosis factor and interleukin-6-Induced osteoclasts in rheumatoid arthritis. Arthritis & Rheumatology (Hoboken N J). 2021;73(7):1145–54.

    Article  CAS  Google Scholar 

  25. Zhang X, et al. Evaluation of bone mineral density and body compositions interrelation in young and middle-aged male patients with Crohn’s disease by quantitative computed tomography. Front Endocrinol. 2022;13:953289.

    Article  Google Scholar 

  26. Fraunberger P, et al. Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock (Augusta Ga). 2006;26(1):10–2.

    Article  CAS  PubMed  Google Scholar 

  27. Kaizu Y, et al. Association between inflammatory mediators and muscle mass in long-term hemodialysis patients. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2003;42(2):295–302.

    Article  CAS  Google Scholar 

  28. Li CW, et al. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. 2022;13(2):781–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Mo C, Du Y, O’Connell TM. Applications of Lipidomics to Age-Related Musculoskeletal Disorders. Curr Osteoporos Rep. 2021;19(2):151–7.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Li F, et al. Myokines and adipokines: involvement in the crosstalk between skeletal muscle and adipose tissue. Cytokine Growth Factor Rev. 2017;33:73–82.

    Article  PubMed  Google Scholar 

  31. Peng J, Yin L, Wang X. Central and peripheral leptin resistance in obesity and improvements of exercise. Horm Behav. 2021;133:105006.

    Article  CAS  PubMed  Google Scholar 

  32. Aleffi S, et al. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology (Baltimore MD). 2005;42(6):1339–48.

    Article  CAS  PubMed  Google Scholar 

  33. Yamauchi T, Kadowaki T. Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metabol. 2013;17(2):185–96.

    Article  CAS  Google Scholar 

  34. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26(3):439–51.

    Article  CAS  PubMed  Google Scholar 

  35. Iwabu M, et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by ca(2+) and AMPK/SIRT1. Nature. 2010;464(7293):1313–9.

    Article  CAS  PubMed  Google Scholar 

  36. Lenchik L, et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone. 2003;33(4):646–51.

    Article  CAS  PubMed  Google Scholar 

  37. Peng X-D, et al. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in chinese men. Clin Chim Acta. 2008;387(1–2):31–5.

    Article  CAS  PubMed  Google Scholar 

  38. Napoli N, et al. Adiponectin and bone mass density: the InCHIANTI study. Bone. 2010;47(6):1001–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Luo X-H, et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Mineral Research: Official J Am Soc Bone Mineral Res. 2006;21(10):1648–56.

    Article  CAS  Google Scholar 

  40. Saijo S, et al. Inhibition by adiponectin of IL-8 production by human macrophages upon coculturing with late apoptotic cells. Biochem Biophys Res Commun. 2005;334(4):1180–3.

    Article  CAS  PubMed  Google Scholar 

  41. Gokulakrishnan K, et al. Augmentation of RBP4/STRA6 signaling leads to insulin resistance and inflammation and the plausible therapeutic role of vildagliptin and metformin. Mol Biol Rep. 2021;48(5):4093–106.

    Article  CAS  PubMed  Google Scholar 

  42. Moraes-Vieira PM, et al. Retinol binding protein 4 primes the NLRP3 inflammasome by signaling through toll-like receptors 2 and 4. Proc Natl Acad Sci USA. 2020;117(49):31309–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Tengesdal IW, et al. Tumor NLRP3-Derived IL-1β drives the IL-6/STAT3 Axis resulting in sustained MDSC-Mediated immunosuppression. Front Immunol. 2021;12:661323.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Chang C-L et al. Serum Retinol Binding Protein 4 as a Potential Biomarker for Sarcopenia in Older Adults The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 2023. 78(1): p. 34–41.

  45. Ghorpade DS, et al. Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. Nature. 2018;555(7698):673–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Bi J, et al. Protective effect of vildagliptin on TNF-α-induced chondrocyte senescence. IUBMB Life. 2019;71(7):978–85.

    CAS  PubMed  Google Scholar 

  47. Zhong J, et al. A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation. Diabetes. 2013;62(1):149–57.

    Article  CAS  PubMed  Google Scholar 

  48. Bouchi R, et al. Dipeptidyl peptidase 4 inhibitors attenuates the decline of skeletal muscle mass in patients with type 2 diabetes. Volume 34. Diabetes/metabolism Research and Reviews; 2018. 2.

  49. Rizzo MR, et al. Sarcopenia in Elderly Diabetic Patients: role of Dipeptidyl Peptidase 4 inhibitors. J Am Med Dir Assoc. 2016;17(10):896–901.

    Article  PubMed  Google Scholar 

  50. Zheng T, et al. Plasma DPP4 activities are Associated with osteoporosis in Postmenopausal Women with normal glucose tolerance. J Clin Endocrinol Metab. 2015;100(10):3862–70.

    Article  CAS  PubMed  Google Scholar 

Download references


The research was supported by grants from the National Key R&D Program of China (2018YFC2002000), the National Natural Science Foundation of China (82071581, 82104790), and the Shanghai Medical Leadership Training Program (2019LJ09).

Author information

Authors and Affiliations



Zhijun Bao, Tao Wu, Shiwen Wang and Wenhao Wang had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Zhijun Bao, Tao Wu, Wenhao Wang and Xiaojun Wang. Experiments: Shiwen Wang, Xuchao Gu and Ziyi Cao. Acquisition, analysis, or interpretation of data: Wenhao Wang, Xuchao Gu, Ziyi Cao, Yiming Lei, Liyang Shen and Xiaoli Xu. Drafting of the manuscript: Shiwen Wang, Wenhao Wang, Xiaojun Wang and Xuchao Gu.

Corresponding authors

Correspondence to Shiwen Wang, Tao Wu or Zhijun Bao.

Ethics declarations

Ethics approval and consent to participate

Our study protocol was approved by the Ethics Committee of Huadong Hospital (Approval no. 2021K114) and was conducted in accordance with the guidelines of the Declaration of Helsinki.

Consent for publication

All authors read and approved this manuscript for publication.

Competing interests

All authors have declared no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, W., Gu, X., Cao, Z. et al. A potential correlation between adipokines, skeletal muscle function and bone mineral density in middle-aged and elderly individuals. Lipids Health Dis 22, 111 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Skeletal muscle function
  • Bone mineral density
  • Adipokine
  • Inflammation